Welcome to the very first episode of Seizure Diaries, where science meets hope in the fight against epilepsy. In this premiere conversation, listeners are introduced to the urgent and evolving world of epilepsy treatment, particularly for those who live with drug-resistant seizures.

This episode sets the stage for what’s to come—groundbreaking ideas, expert voices, and a deep commitment to changing lives through advanced neurological care.

Listeners will hear:

• the science behind neuromodulation

• real-world needs in current epilepsy treatment

• how Cadence is working to bridge gaps in treatment with new therapies

This episode provides a foundational understanding of how collaborative research and cutting-edge technology are opening new possibilities for seizure control—and why this work matters now more than ever.

More about Cadence Neuroscience:

Cadence Neuroscience is currently developing an investigational BTS [Biomarker Targeting Stimulation] device therapy for the treatment of drug-resistant focal epilepsy, based on pioneering work performed by researchers at Mayo Clinic. Learn more at cadenceneuro.com.

For those living with epilepsy, a life without seizures truly is freedom.

In this podcast, hosts Cadence Neuroscience CEO Kent Leyde and Chief Scientific Officer Doug Sheffield discuss their work toward ending epileptic seizures.

From their own innovative medical technology to other advances in the field, Kent and Doug’s conversations with guests investigate the impact epilepsy has and the work being done locally and globally to ensure every person lives a seizure-free life.